Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) ...
Highly diverse molecular libraries have recently become a vital tool in the search for molecules with novel properties. The antibody molecule in particular has been the focus of extensive development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback